Sign in
8-K

Current Report

Regen BioPharma Inc Filed Acc 0001607062-14-000097

Shareholder rights changed

  • Item 3.03 Material modification to rights of security holders

From the SEC's structured data for this filing

Loading regen20140918form8k.htm…